Anxiofit Ltd.

18 Nyul street,

1025 Budapest, Hungary

+3670 602 9530

  • LinkedIn - Black Circle

© 2019 by Anxiofit Ltd.



Nature and Science together

Developer of evidence-based, anti-anxiety dietary supplements


Anxiofit is a developer of evidence-based, anti-anxiety dietary supplements.  The development is built on deep scientific knowledge, research and numerous animal and human trials to be able to provide proven help for the large population of people occasionally experiencing anxiety, stress, nervous tension, and even restless sleep.

The company’s first product, Anxiofit-1, which started to be marketed under AnxioCalm brand in the US is mainly built on the valuable ingredients of a traditional herb: Echinacea. 

Echinacea is traditionally used for immune support, but a unique breed of Echinacea Angustifolia, standardized for selected rare active ingredients, has proven anxiolytic effects.

The company started commercialization of the product and is searching for distributors globally. 


The company was founded in 2007 by well-known Hungarian scientists, Prof. Tamas FreundProf. Jozsef Haller and the Hungarian Academy of Sciences.   Research started by utilizing governmental and EU grant to gain a better understanding of the anxiolytic effects of certain herbs and compounds.  In the research process special emphasis were given to the endocannabinoid system, CB1 and CB2 receptors.  

They found that ingredients of a certain kind of Echinacea has anxiolytc effects.  The effect highly depends on the breed, where the plants are grown, which part of the plant is used, and how it is processed.   

Scientific articles have been published about the anxiolitic effects of Echinacea and patents have been filed by the company and its founding scientists. The company has tested a lot of suppliers and only a few were able to supply raw materials for the production. Methods have been developed to ensure that the final products always have the right proportion of active ingredients responsible for the anxiolytic effect, as some ingredients in Echinacea might even increase anxiety.  


In 2009 together with a reputable GMP certified pharma manufacturer (ExtractumPharma) the company developed the  Anxiofit-1 diatery supplement and started production of the 20mg Anxiofit-1 pills in pharma quality.

Numerous animal and human clinical trials have been completed to prove that Anxiofit-1, without sideefects, is ameliorateing sub-threshold and mild anxiety, which are clear risk factors in develompent of anxiety disorders and depression.


In 2010 the first products appeared in the US market under Anxiofit brand, which was later rebranded to AnxioCalm and is exclusively distributed by Europharma Inc.

In 2016 the AnxioCalm product received licenses for distribution also in Canada.

Anxiofit is currently working on receiving an EFSA approval to be able to use its anti-anxiety health claim on the labels also in the European countries.


The company is working on to combine extracts of other traditional herbs and dietary suppliment with its Echinacea extract to be able to increase the anti-anxiety effect of the current product without the appearence of any side effects.

The company started to search for distribution partners globally.


Tamás F. Freund is a Director of the Institute of Experimental Medicine, and Chairman of the Neuroscience Department, P. Pazmany Catholic University. He has been President of the Federation of European Neuroscience Soceities and he is a vice president of the Hungarian Academy of Sciences, and has been a member of the Academia Europaea, the German Academy of Sciences Leopoldina, the Academia Scientiarum et Artium Europaea, and the American Academy of Arts and Sciences. The major awards he received include the KRIEG Cortical Discoverer Award and the Cajal Medal (U.S.A.), the Bolyai Prize (Hungary), the Szechenyi Prize, (HU), The Brain Prize (Denmark), and the Prima Primissima award (HU).


Main areas of research: neuronal microcircuits, brain research, synaptic and molecular organization, functional architecture and physiology of neuronal circuits. His work around CB1 cannabinoid receptors, inhibiting neurotransmitter release are important for the development of Anxiofit. 

Chairman of the Board, Founder, Biologist

Prof. Tamás F. Freund


The AnxioCalm dietary supplement in the US is targeting the large population of people experiencing occasional anxiety, not receiving conventional medical treatment and favouring side effect free herbal medications, which has scientifically described mechanism of action and a measurable effect.

The pills consist of only 20mg active ingredients, which is significantly lower compared to other medications, making it a safe treatment even for children.  Traditionally Echinacea is used safely in a significantly higher dosage for boosting the immune system for generations.  None of the clinical trials done by the company reported any side efects.


Benefits of Anxiocalm​

  • Fast action, noticeable change in a few days.  

  • Calming effect remains for weeks even after finishing a 2 week treatment.

  • Low dose

  • Manufactured in pharma quality in GMP licensed factory with independent testing for quality

  • More than 8 years in the US market without any side effects reported

  • Based on scientific evidence

  • Non-GMO, no synthetic pesticides or herbicides